~~<i id='37323963C1'><strike id='37323963C1'><tt id='37323963C1'><pre id='37323963C1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：fashion 2025-10-03 00:41:10 - browse：884

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： What it’s like to watch children die of measles

hotspot

explore

entertainment

hotspot

knowledge

High-risebuildingsindowntownLosAngelesseenonahazymorning.FREDERICJ.BROWN/AFPviaGettyImagesTheU.S.ism

WSS

Change Healthcare payments predicted restored March 15

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Biotech venture capitalists face new demands from investors

EU regulator recommends expanding Mounjaro approval to obesity

Change Healthcare cyberattack prompts Medicare loan program

Air quality improving but still lags in Black, Hispanic communities

focus

comprehensive

hotspot

Walensky prepares to leave CDC — and Congress — behind

How to bring more disabled researchers into academia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sen. Paul opposes bill to ban Chinese biotechs

United colonoscopy coverage change 'may cost lives,' doctors say

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Cancer drug shortages should be causing more outrage

AI generated plenty of interest at JPM but not a lot of trust

Medical records are filled with copy

CDC marks new Covid

explore

Elizabeth Holmes banned from government health programs

In his State of the Union, Biden takes clear aim at 'Big Pharma'

CDC marks new Covid

Elizabeth Holmes banned from government health programs

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Parkinson’s finding may lead to tests and, someday, treatments

entertainment

hotspot

hotspot

knowledge